Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Non-cash Items (2020 - 2024)

Historic Non-cash Items for HCW Biologics (HCWB) over the last 5 years, with Q4 2024 value amounting to $799393.0.

  • HCW Biologics' Non-cash Items rose 23558.33% to $799393.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $799393.0, marking a year-over-year increase of 23558.33%. This contributed to the annual value of $799393.0 for FY2024, which is 23558.33% up from last year.
  • HCW Biologics' Non-cash Items amounted to $799393.0 in Q4 2024, which was up 23558.33% from $238210.0 recorded in Q4 2023.
  • HCW Biologics' 5-year Non-cash Items high stood at $1.1 million for Q4 2021, and its period low was $88531.0 during Q4 2020.
  • Moreover, its 5-year median value for Non-cash Items was $473686.0 (2022), whereas its average is $544807.0.
  • As far as peak fluctuations go, HCW Biologics' Non-cash Items surged by 116985.46% in 2021, and later plummeted by 5786.52% in 2022.
  • HCW Biologics' Non-cash Items (Quarter) stood at $88531.0 in 2020, then skyrocketed by 1169.85% to $1.1 million in 2021, then crashed by 57.87% to $473686.0 in 2022, then tumbled by 49.71% to $238210.0 in 2023, then skyrocketed by 235.58% to $799393.0 in 2024.
  • Its last three reported values are $799393.0 in Q4 2024, $238210.0 for Q4 2023, and $473686.0 during Q4 2022.